124 results
8-K
EX-99.1
IMNM
Immunome Inc
28 Mar 24
Immunome Reports Full-Year 2023 Financial Results and Provides Update on Recently Acquired Assets
4:04pm
statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act
8-K
EX-99.1
IMNM
Immunome Inc
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
Securities Litigation Reform Act of 1995 (the “PSLRA”). We use words such as “may,” “could,” “potential,” “will,” “plan,” “believe,” and similar
8-K
EX-10.1
9uk8 ot9l99cw
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
8-K
396ns0shf 2adfip9
26 Mar 24
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
8:05am
8-K
EX-1.1
lmlbeu1ztg
14 Feb 24
Other Events
4:11pm
8-K
kbz8elrfz40a
14 Feb 24
Other Events
4:11pm
424B5
ocf r7hv8ts
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
qhhmq dki2gvt
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.1
8bh72ps1
13 Feb 24
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.2
8s8 aq5vzsb75
13 Feb 24
Results of Operations and Financial Condition
4:10pm
S-3ASR
EX-4.4
kvhcymxnddaymh5
13 Feb 24
Automatic shelf registration
4:04pm
S-3ASR
EX-4.3
3wf4b
13 Feb 24
Automatic shelf registration
4:04pm
8-K
EX-2.1
e3xcdmi c0069n8
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
4gqf04 2a5h
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
EX-10.1
t03mf 617jkte3ldxse
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
EX-99.1
ose2fva8p
6 Feb 24
Immunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
8:05am
8-K
EX-99.1
4mtnok
11 Jan 24
Regulation FD Disclosure
5:27pm